GHSC-PSM in Lesotho then engaged the GHSC-PSM Headquarters Supply Chain Unit to help identify countries that were in need of the product. “On behalf of the Ministry of Health Zambia and indeed the National TB Program, we are very grateful for your efficient facilitation of the donation of the INH 300mg tablets from Lesotho. This will go a long way in covering the gap and the potential to avert the stock out of one key TB preventive treatment (or TPT) treatment option in the country. The donated tablets will help the program to completely treat about 30,000 TPT-eligible patients in our facilities”, said Zambia’s MOH representative.
Zambia and Haiti were the two countries identified. By the end of October 2021, the project in Lesotho had collaborated with the GHSC-PSM Headquarters Supply Chain Unit to facilitate all formal processes for the product donation to the two countries. Lesotho was finally able to donate IHM 300mg tablets—7,941x672 to Zambia and 1,000x672 tablets to Haiti—in November 2021.
To reduce the risk of latent to active TB, WHO recommends Tuberculosis Preventive Treatment (TPT) for people with HIV/AIDS, with the most common regimen for latent TB infection currently being isoniazid preventive therapy (IPT), as well as a new shorter regimen called 3HP (a weekly dose of rifapentine and isoniazid for 3 months), which significantly reduces treatment duration as well as pill burden for patients over the course of therapy.